TETRACYCLINE HYDROCHLORIDE capsule USA - engelsk - NLM (National Library of Medicine)

tetracycline hydrochloride capsule

liberty pharmaceuticals, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

TETRACYCLINE HYDROCHLORIDE capsule USA - engelsk - NLM (National Library of Medicine)

tetracycline hydrochloride capsule

rebel distributors corp - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

TETRACYCLINE HYDROCHLORIDE capsule USA - engelsk - NLM (National Library of Medicine)

tetracycline hydrochloride capsule

blenheim pharmacal, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog

Tetracycline HCl 250 mg PCH, capsules Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

tetracycline hcl 250 mg pch, capsules

pharmachemie b.v. - tetracycline hydrochloride - capsule, hard - chinolinegeel (e 104) ; erythrosine (e 127) ; gelatine (e 441) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat ; titaandioxide (e 171), chinolinegeel (e 104) ; erythrosine (e 127) ; gelatine (e 441) ; lactose 1-water ; magnesiumstearaat (e 470b) ; natriumzetmeelglycolaat (e468) ; titaandioxide (e 171), - tetracycline

ACHROMYCIN V - tetracycline hcl capsule USA - engelsk - NLM (National Library of Medicine)

achromycin v - tetracycline hcl capsule

heritage pharmaceuticals inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of achromycin v (tetracycline hcl capsules, usp) and other antibacterial drugs, achromycin v (tetracycline hcl capsules, usp) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. achromycin v (tetracycline hcl capsules, usp) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: achromycin v (tetracycline hcl capsules, usp) should not be used for streptococcal disease unless the organism ha

Oxytetracycline 80 % Kela 863,20 mg/g pdr. voor drinkwater/melk Belgia - nederlandsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

oxytetracycline 80 % kela 863,20 mg/g pdr. voor drinkwater/melk

kela laboratoria - oxytetracyclinehydrochloride 863.2 mg/g - eq. oxytetracycline 800 mg/g - poeder voor toediening in het drinkwater/in de melk - 863,20 mg/g - oxytetracyclinehydrochloride 863.2 mg/g - oxytetracycline - rund; varken

Oxytetracycline 10% inj. Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

oxytetracycline 10% inj.

dutch farm international b.v. - oxytetracycline - oplossing voor injectie - oxytetracycline 100 mg/ml, - oxytetracycline - varkens

Oxytetracycline 10% pro inj 100 mg/ml, oplossing voor injectie voor rund, varken, hond en kat Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

oxytetracycline 10% pro inj 100 mg/ml, oplossing voor injectie voor rund, varken, hond en kat

alfasan nederland b.v. - oxytetracyclinehydrochloride - oplossing voor injectie - oxytetracyclinehydrochloride 100 mg/ml, - oxytetracycline - honden; katten; runderen; varkens

Oxytetracycline 40% W.O. Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

oxytetracycline 40% w.o.

dutch farm international b.v. - oxytetracyclinehydrochloride - poeder voor oraal gebruik - oxytetracyclinehydrochloride 400 mg/g, - oxytetracycline - kippekuikens; vleesvarkens

Oxytetracycline 40% WSP, 400 mg/g poeder voor oraal gebruik voor varkens Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

oxytetracycline 40% wsp, 400 mg/g poeder voor oraal gebruik voor varkens

kepro b.v. - oxytetracyclinehydrochloride - poeder voor oraal gebruik - oxytetracyclinehydrochloride 400 mg/g, - oxytetracycline - varkens